Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7492619rdf:typepubmed:Citationlld:pubmed
pubmed-article:7492619lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:7492619lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:7492619lifeskim:mentionsumls-concept:C0227525lld:lifeskim
pubmed-article:7492619lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:7492619lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:7492619lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:7492619lifeskim:mentionsumls-concept:C0678406lld:lifeskim
pubmed-article:7492619pubmed:issue1lld:pubmed
pubmed-article:7492619pubmed:dateCreated1996-1-11lld:pubmed
pubmed-article:7492619pubmed:abstractTextThe oxidation, esterification and formation of chain elongated and desaturated products of [1-14C]5,8,11-eicosatrienoic (Mead) acid was studied. Liver cells from essentially fatty acid deficient (EFAD) and control rats were used. The metabolism of [1-14C]20:4, n-6 and [1-14C]20:5, n-3 were studied under the same experimental conditions. More 20:3, n-9 than 20:4, n-6 and 20:5, n-3 was oxidised both in EFAD and control cells. 20:3, n-9 was elongated to [14C]22:3, n-9 in both cell types and significant amounts of [14C]22:4, n-9 were formed in EFAD cells. Less 20:3, n-9 was esterified in phospholipids and more in triacylglycerol than observed with 20:4, n-6 and 20:5, n-3 in both cell types. 20:3, n-9 was mainly esterified in phosphatidylcholine and little was esterified in phosphatidylethanolamine compared to 20:4, n-6 and 20:5, n-3. In comparison, 20:3, n-9 was rather efficiently esterified in phosphatidylinositol as 18:0-20:3. [14C]22:4, n-9 formed from 20:3, n-9 in EFAD hepatocytes was esterified in triacylglycerol, not in phospholipids, unlike [14C]22:5, n-6 and [14C]22:6, n-3 which were mainly esterified in phospholipids.lld:pubmed
pubmed-article:7492619pubmed:languageenglld:pubmed
pubmed-article:7492619pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7492619pubmed:citationSubsetIMlld:pubmed
pubmed-article:7492619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7492619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7492619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7492619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7492619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7492619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7492619pubmed:statusMEDLINElld:pubmed
pubmed-article:7492619pubmed:monthOctlld:pubmed
pubmed-article:7492619pubmed:issn0006-3002lld:pubmed
pubmed-article:7492619pubmed:authorpubmed-author:Christopherse...lld:pubmed
pubmed-article:7492619pubmed:authorpubmed-author:RetterstølKKlld:pubmed
pubmed-article:7492619pubmed:authorpubmed-author:WoldsethBBlld:pubmed
pubmed-article:7492619pubmed:issnTypePrintlld:pubmed
pubmed-article:7492619pubmed:day26lld:pubmed
pubmed-article:7492619pubmed:volume1259lld:pubmed
pubmed-article:7492619pubmed:ownerNLMlld:pubmed
pubmed-article:7492619pubmed:authorsCompleteYlld:pubmed
pubmed-article:7492619pubmed:pagination82-8lld:pubmed
pubmed-article:7492619pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:meshHeadingpubmed-meshheading:7492619-...lld:pubmed
pubmed-article:7492619pubmed:year1995lld:pubmed
pubmed-article:7492619pubmed:articleTitleStudies on the metabolism of [1-14C]5.8.11-eicosatrienoic (Mead) acid in rat hepatocytes.lld:pubmed
pubmed-article:7492619pubmed:affiliationInstitute of Clinical Biochemistry, University of Oslo, Rikshospitalet, Norway.lld:pubmed
pubmed-article:7492619pubmed:publicationTypeJournal Articlelld:pubmed